Duplančić, R., Roguljić, M., Božić, D. & Kero, D. (2022). Heparan Sulfate Glycosaminoglycan Is Predicted to Stabilize Inflammatory Infiltrate Formation and RANKL/OPG Ratio in Severe Periodontitis in Humans. Bioengineering, 9. (10). doi: 10.3390/bioengineering9100566
Duplančić, Roko, et al. "Heparan Sulfate Glycosaminoglycan Is Predicted to Stabilize Inflammatory Infiltrate Formation and RANKL/OPG Ratio in Severe Periodontitis in Humans." Bioengineering, vol. 9, no. 10, 2022. https://doi.org/10.3390/bioengineering9100566
Duplančić, Roko, Marija Roguljić, Darko Božić and Darko Kero. "Heparan Sulfate Glycosaminoglycan Is Predicted to Stabilize Inflammatory Infiltrate Formation and RANKL/OPG Ratio in Severe Periodontitis in Humans." Bioengineering 9, no. 10 (2022). https://doi.org/10.3390/bioengineering9100566
Duplančić, R., et al. (2022) 'Heparan Sulfate Glycosaminoglycan Is Predicted to Stabilize Inflammatory Infiltrate Formation and RANKL/OPG Ratio in Severe Periodontitis in Humans', Bioengineering, 9(10). doi: 10.3390/bioengineering9100566
Duplančić R, Roguljić M, Božić D, Kero D. Heparan Sulfate Glycosaminoglycan Is Predicted to Stabilize Inflammatory Infiltrate Formation and RANKL/OPG Ratio in Severe Periodontitis in Humans. Bioengineering [Internet]. 2022 October 18 [cited 2024 August 25];9(10). doi: 10.3390/bioengineering9100566
R. Duplančić, M. Roguljić, D. Božić and D. Kero, "Heparan Sulfate Glycosaminoglycan Is Predicted to Stabilize Inflammatory Infiltrate Formation and RANKL/OPG Ratio in Severe Periodontitis in Humans", Bioengineering, vol. 9, no. 10, October 2022. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:127:109850. [Accessed: 25 August 2024]